Biomedical Catalyst 2019 Round 1: Early and Late Stage Awards

Funding opportunity:

Biomedical Catalyst 2019 Round 1: Early and Late Stage Awards

Status:

Closed

Funder and programme:

Innovate UK and Medical Research Council (MRC) – Biomedical Catalyst

Project total costs (range):

£ 250,000 – £ 4,000,000

Opens:

21/01/2019

Competition closes:

03/04/2019 (12:00 noon)

UK businesses can apply for a share of up to £7 million to explore and evaluate the commercial potential of a scientific idea to solve a healthcare challenge.

The aim of the Biomedical Catalyst is to support the development of innovative healthcare products, technologies and processes. These can include (but are not limited to):

  • disease prevention and proactive management of health and chronic conditions;
  • earlier and better detection and diagnosis of disease, leading to better patient outcomes;
  • tailored treatments that either change the underlying disease or offer potential cures.

Your project’s total eligible costs must be between £250,000 and £4 million. Your project must start by 1 September 2019 and end by 31 March 2021. It must last at least 1 year.

Innovate UK and Medical Research Council (MRC) are also running a combined Feasibility and Primer Award competition. Make sure you are applying for the correct competition.

MSC R&D can help your business develop by supporting you in:
• Identification of appropriate grants and competition calls for proposals
• Partner search for collaborative Research & Innovation
• Bid writing
• Project management
• Audit compliance
• Commercialisation
• Business Planning
• Market Intelligence reports

If you want help with any of these opportunities, please CONTACT us on 0114 230 8401 or email businessdevelopment@mscbdg.co.uk